A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Institut Bergonié
University of Wisconsin, Madison
Mayo Clinic
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Rutgers, The State University of New Jersey
University of Utah
Case Comprehensive Cancer Center